Digitalizing biopharma: How raw material data can maximize biopharma supply chain and manufacturing practices
As the transformation of biopharmaceutical manufacturing continues to evolve, biopharmaceutical manufacturers and raw material suppliers are entering the frontier of “biopharma 4.0” where AI, big data and smart systems are being leveraged to help transform the business model.
From incoming good receipts and raw material testing, to process development, manufacturing troubleshooting and predictive analytics targeting consistent and predictable biomanufacturing, data exchange programs with raw material manufacturers can have an immediate impact in the journey of creating a digital biomanufacturing process that reduces cost and improves productivity.
This presentation was given as part of BPI Spring Digital Week, Monday, 22nd June, 2020.
Presented by:
 |
|
Claudia Berrón, Senior Vice President, Business Development and Commercial Operations - BioPharma Production, Avantor
Claudia has over two decades of experience in B2B strategic marketing covering ideation, value proposition strategies, market segmentation, marketing and sales planning through product launch, and has been working with Avantor since 2015. She holds an MBA from the University of North Carolina Kenan-Flagler Business School in Chapel Hill, North Carolina, and a bachelor’s degree from Monterrey Institute of Technology in Mexico City. |
